Hannah L. McLellan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hannah L. McLellan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Dick H. J. Thijssen
Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands
3 shared publications - Ellen Adele Dawson
School of Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK
3 shared publications - Esmee A. Bakker
Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands
2 shared publications - Thijs M. H. Eijsvogels
Department of Medical BioSciences, Exercise Physiology Research Group, Radboud University Medical Center , Nijmegen
2 shared publications - Andrew Haynes
School of Human Sciences (Exercise and Sport Science), University of Western Australia, Perth, Australia
1 shared publication Andrew J. Maiorana
School of Human Sciences (Exercise and Sport Science), The University of Western Australia, Perth, Australia
1 shared publication
Latest Publications
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (9) , 2231-2239
Impact of Hypertension on the Dose-Response Association Between Physical Activity and Stroke: A Cohort Study
BACKGROUND: Regular physical activity is associated with a reduced stroke risk. However, this relationship might be attenuated in the presence of hypertension and antihypertensive medication use. We examined the dose-response relationship between physical activity and stroke in normotensive and hypertensive individuals. METHODS: A Dutch population-based cohort including 139 930 individuals (41% men; mean age, 44±13) was performed (median follow-up, 6.75 years). Participants were stratified at baseline as hypertensive (44%) or normotensive (56%) and categorized into quartiles of the lowest (Q1) to the highest (Q4) moderate-to-vigorous, self-reported physical activity. The primary outcome was incident stroke (fatal and nonfatal). Cox regression estimated hazard ratios and 95% CIs. The main analyses were stratified on baseline blood pressure and adjusted for confounders. Hypertensives were stratified into medicated (21%) or non-medicated (79%). RESULTS: Compared with Q1, adjusted hazard ratios were 0.87 (0.69–1.10; P =0.23), 0.75 (0.59–0.95; P =0.02), and 0.94 (0.74–1.20; P =0.64) for Q2 to Q4, respectively in the total population. Hazard ratios for normotensives were 0.79 (0.50–1.25; P =0.32), 0.75 (0.48–1.18; P =0.22), 0.97 (0.62–1.51; P =0.90) for Q2 to Q4, respectively. In hypertensives, hazard ratios were 0.89 (0.68–1.17; P =0.41), 0.74 (0.56–0.98; P =0.03), 0.92 (0.69–1.23; P =0.56) for Q2 to Q4, respectively. There was no significant interaction between hypertension status for the relation between physical activity and stroke risk. The stratified analysis revealed a smaller benefit of moderate-to-vigorous physical activity in medicated hypertensives compared with nonmedicated hypertensives, but no significant interaction effect was found. CONCLUSIONS: Regular moderate-to-vigorous physical activity is beneficial for stroke risk reduction (Q3 compared with Q1), which is not affected by hypertension. Antihypertensive medication may be associated with a smaller benefit of moderate-to-vigorous physical activity on the risk of stroke, but further research is warranted.
- 1 September 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (9) , 2231-2239
Open AccessImpact of Hypertension on the Dose-Response Association Between Physical Activity and Stroke: A Cohort Study
BACKGROUND: Regular physical activity is associated with a reduced stroke risk. However, this relationship might be attenuated in the presence of hypertension and antihypertensive medication use. We examined the dose-response relationship between physical activity and stroke in normotensive and hypertensive individuals. METHODS: A Dutch population-based cohort including 139 930 individuals (41% men; mean age, 44±13) was performed (median follow-up, 6.75 years). Participants were stratified at baseline as hypertensive (44%) or normotensive (56%) and categorized into quartiles of the lowest (Q1) to the highest (Q4) moderate-to-vigorous, self-reported physical activity. The primary outcome was incident stroke (fatal and nonfatal). Cox regression estimated hazard ratios and 95% CIs. The main analyses were stratified on baseline blood pressure and adjusted for confounders. Hypertensives were stratified into medicated (21%) or non-medicated (79%). RESULTS: Compared with Q1, adjusted hazard ratios were 0.87 (0.69–1.10; P =0.23), 0.75 (0.59–0.95; P =0.02), and 0.94 (0.74–1.20; P =0.64) for Q2 to Q4, respectively in the total population. Hazard ratios for normotensives were 0.79 (0.50–1.25; P =0.32), 0.75 (0.48–1.18; P =0.22), 0.97 (0.62–1.51; P =0.90) for Q2 to Q4, respectively. In hypertensives, hazard ratios were 0.89 (0.68–1.17; P =0.41), 0.74 (0.56–0.98; P =0.03), 0.92 (0.69–1.23; P =0.56) for Q2 to Q4, respectively. There was no significant interaction between hypertension status for the relation between physical activity and stroke risk. The stratified analysis revealed a smaller benefit of moderate-to-vigorous physical activity in medicated hypertensives compared with nonmedicated hypertensives, but no significant interaction effect was found. CONCLUSIONS: Regular moderate-to-vigorous physical activity is beneficial for stroke risk reduction (Q3 compared with Q1), which is not affected by hypertension. Antihypertensive medication may be associated with a smaller benefit of moderate-to-vigorous physical activity on the risk of stroke, but further research is warranted.
- Open Access
- 31 January 2024
- Published by Springer Nature in Journal of Science in Sport and Exercise
- Vol. 7 (2) , 197-205
Relation Between Endothelial Dysfunction and Exercise Training-Mediated Adaptation in Cardiovascular Risk Factors, Cardiorespiratory Fitness, and Vascular Health in Humans: A secondary analysis
Purpose: A priori cardiovascular (CV) health status may impact reductions in risk factors and CV mortality and morbidity following exercise training, although this is not fully understood. Therefore, the purpose of the study was to examine if endothelial function (assessed via flow mediated dilation; FMD%), predicts the magnitude of change in CV risk factors or fitness following exercise training. Methods: We pooled data from 338 individuals who underwent supervised exercise training (8–26 weeks). Using recent sex- and age-specific reference values for flow-mediated dilation (FMD%), we categorised participants as having preserved endothelial function (P-EF) (> 50th percentile of reference value, 56 females, 67 males, 46 ± 17 years) or reduced endothelial function (R-EF) (< 50th percentile of reference value, 67 females, 148 males, 48 ± 17 years). The effects of exercise training on cardiovascular risk factors (BMI, cholesterol, glucose and triglycerides), cardiorespiratory fitness (VO2peak) and vascular function (FMD%) were examined using a two-way mixed design general linear model. Results: Exercise training significantly improved physical fitness (P < 0.001), with no difference in the magnitude of improvement between P-EF and R-EF. Modest but significant reductions were present in BMI, blood pressure and total cholesterol (all P < 0.005), with no difference between P-EF and R-EF groups in the magnitude of changes in these variables with training. Exercise training did not significantly alter glucose, triglycerides, high density lipoprotein (HDL) and low-density lipoprotein (LDL) (all P > 0.05). Conclusion: Individuals with reduced and preserved a priori endothelial function status can obtain benefits from exercise in terms of risk factor modification and fitness change. Therefore, exercise has the potential to be beneficial in all clinical groups.
- 31 January 2024
- Published by Springer Nature in Journal of Science in Sport and Exercise
- Vol. 7 (2) , 197-205
Open AccessRelation Between Endothelial Dysfunction and Exercise Training-Mediated Adaptation in Cardiovascular Risk Factors, Cardiorespiratory Fitness, and Vascular Health in Humans: A secondary analysis
Purpose: A priori cardiovascular (CV) health status may impact reductions in risk factors and CV mortality and morbidity following exercise training, although this is not fully understood. Therefore, the purpose of the study was to examine if endothelial function (assessed via flow mediated dilation; FMD%), predicts the magnitude of change in CV risk factors or fitness following exercise training. Methods: We pooled data from 338 individuals who underwent supervised exercise training (8–26 weeks). Using recent sex- and age-specific reference values for flow-mediated dilation (FMD%), we categorised participants as having preserved endothelial function (P-EF) (> 50th percentile of reference value, 56 females, 67 males, 46 ± 17 years) or reduced endothelial function (R-EF) (< 50th percentile of reference value, 67 females, 148 males, 48 ± 17 years). The effects of exercise training on cardiovascular risk factors (BMI, cholesterol, glucose and triglycerides), cardiorespiratory fitness (VO2peak) and vascular function (FMD%) were examined using a two-way mixed design general linear model. Results: Exercise training significantly improved physical fitness (P < 0.001), with no difference in the magnitude of improvement between P-EF and R-EF. Modest but significant reductions were present in BMI, blood pressure and total cholesterol (all P < 0.005), with no difference between P-EF and R-EF groups in the magnitude of changes in these variables with training. Exercise training did not significantly alter glucose, triglycerides, high density lipoprotein (HDL) and low-density lipoprotein (LDL) (all P > 0.05). Conclusion: Individuals with reduced and preserved a priori endothelial function status can obtain benefits from exercise in terms of risk factor modification and fitness change. Therefore, exercise has the potential to be beneficial in all clinical groups.
- Open Access
The impact of hypertension on the dose-response association between physical activity and stroke: A cohort study among 139,930 adults from the Netherlands
Background: There is a strong dose-response relationship between regular physical activity (PA) and stroke risk. However, this relationship is attenuated in the presence of cardiovascular risk. This study aimed to compare the dose-response relationship between PA and stroke between normo- and hypertensive individuals. Methods: A cohort study including 139,930 individuals was performed (median follow up: 6.75 years). Participants were stratified at baseline as hypertensive or normotensive and were categorised into quartiles of lowest (Q1) to highest (Q4) moderate-to-vigorous (MV), self-reported PA. Primary outcome was stroke. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals. The main analyses were stratified on baseline blood pressure and adjusted for confounders. Additionally, hypertensives were stratified into medicated or not medicated. Results: Compared to Q1, adjusted HRs were 0.87 (0.69-1.10, P =0.23) for Q2, 0.75 (0.59-0.95, P =0.02) for Q3, and 0.94 (0.74-1.20, P =0.64) for Q4 in the total population. In the stratified analyses, HRs for individuals with normotension were 0.79 (0.50-1.25, P =0.32), 0.75 (0.48-1.18, P =0.22), 0.97 (0.62-1.51, P =0.90) for MVPA Q2 to Q4, respectively. In hypertensive individuals, HRs compared to Q1 were 0.89 (0.68-1.17, P =0.41), 0.74 (0.56-0.98, P =0.03), 0.92 (0.69-1.23, P =0.56) for Q2-Q4, respectively. There was no significant interaction between PA and hypertensive status. A smaller benefit of MVPA in medicated hypertensives compared to non-medicated was observed, however the dose-response association was similar. Conclusion: MVPA reduces stroke risk in the total population (Q3), which is not affected by the presence of hypertension. Use of anti-hypertensive medication may interfere with the impact of MVPA on stroke risk. Novelty and Relevance: What is new?: Presence of cardiovascular disease or cardiovascular disease risk factors may alter the dose-response relationship between regular physical activity and major adverse cardiovascular events (MACE) and mortality. No previous study has investigated whether hypertension per se alters the dose-response relationship between regular moderate-to-vigorous physical activity (MVPA) and stroke risk. What is relevant?: This large cohort study demonstrates the importance of regular MVPA on stroke risk reduction particularly in individuals with hypertension. Furthermore, this study provides preliminary indication that the use of antihypertensive medication may alter this association. Clinical/Pathophysiological implications?: The presence of hypertension does not alter the dose-response association between MVPA and stroke. Importantly, this highlights that MVPA is beneficial in reducing the risk of stroke, even in individuals diagnosed with hypertension. Although this cohort study cannot make solid conclusions on the influence of antihypertensive medication, this study reinforces the importance of regular physical activity on the clinical outcome of stroke.
Open AccessThe impact of hypertension on the dose-response association between physical activity and stroke: A cohort study among 139,930 adults from the Netherlands
Background: There is a strong dose-response relationship between regular physical activity (PA) and stroke risk. However, this relationship is attenuated in the presence of cardiovascular risk. This study aimed to compare the dose-response relationship between PA and stroke between normo- and hypertensive individuals. Methods: A cohort study including 139,930 individuals was performed (median follow up: 6.75 years). Participants were stratified at baseline as hypertensive or normotensive and were categorised into quartiles of lowest (Q1) to highest (Q4) moderate-to-vigorous (MV), self-reported PA. Primary outcome was stroke. Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals. The main analyses were stratified on baseline blood pressure and adjusted for confounders. Additionally, hypertensives were stratified into medicated or not medicated. Results: Compared to Q1, adjusted HRs were 0.87 (0.69-1.10, P =0.23) for Q2, 0.75 (0.59-0.95, P =0.02) for Q3, and 0.94 (0.74-1.20, P =0.64) for Q4 in the total population. In the stratified analyses, HRs for individuals with normotension were 0.79 (0.50-1.25, P =0.32), 0.75 (0.48-1.18, P =0.22), 0.97 (0.62-1.51, P =0.90) for MVPA Q2 to Q4, respectively. In hypertensive individuals, HRs compared to Q1 were 0.89 (0.68-1.17, P =0.41), 0.74 (0.56-0.98, P =0.03), 0.92 (0.69-1.23, P =0.56) for Q2-Q4, respectively. There was no significant interaction between PA and hypertensive status. A smaller benefit of MVPA in medicated hypertensives compared to non-medicated was observed, however the dose-response association was similar. Conclusion: MVPA reduces stroke risk in the total population (Q3), which is not affected by the presence of hypertension. Use of anti-hypertensive medication may interfere with the impact of MVPA on stroke risk. Novelty and Relevance: What is new?: Presence of cardiovascular disease or cardiovascular disease risk factors may alter the dose-response relationship between regular physical activity and major adverse cardiovascular events (MACE) and mortality. No previous study has investigated whether hypertension per se alters the dose-response relationship between regular moderate-to-vigorous physical activity (MVPA) and stroke risk. What is relevant?: This large cohort study demonstrates the importance of regular MVPA on stroke risk reduction particularly in individuals with hypertension. Furthermore, this study provides preliminary indication that the use of antihypertensive medication may alter this association. Clinical/Pathophysiological implications?: The presence of hypertension does not alter the dose-response association between MVPA and stroke. Importantly, this highlights that MVPA is beneficial in reducing the risk of stroke, even in individuals diagnosed with hypertension. Although this cohort study cannot make solid conclusions on the influence of antihypertensive medication, this study reinforces the importance of regular physical activity on the clinical outcome of stroke.